< Back to previous page


Comparative performance of genomic methods for the detection of pyrazinamide resistance and heteroresistance in Mycobacterium tuberculosis

Journal Contribution - e-publication

Pyrazinamide is an important component of both drug-susceptible and drug-resistant tuberculosis treatment regimens. Although approximately 50% of rifampin-resistant isolates are also resistant to pyrazinamide, pyrazinamide susceptibility testing is not routinely performed due to the challenging nature of the assay.
Journal: Journal of clinical microbiology
ISSN: 0095-1137
Volume: 60
Publication year:2022
Keywords:A1 Journal article